These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7409887)

  • 1. Evaluation of amikacin dosage regimes in the low and very low birthweight newborn.
    Cookson B; Tripp J; Leung T; Williams JD
    Infection; 1980; 8 Suppl 3():S 239-42. PubMed ID: 7409887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin dosage in the preterm newborn.
    Want SV; Jones AK; Darrell JH
    J Antimicrob Chemother; 1979 Sep; 5(5):527-30. PubMed ID: 500515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory studies with amikacin in newborns, infants, and children.
    Trujillo H; Manotas R; Londono R; Ramirez JI; Uribe A; De Vidal EL; Agudelo N
    J Infect Dis; 1976 Nov; 134 SUPPL():S406-11. PubMed ID: 993632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases.
    Howard JB; McCraken GH; Trujillo H; Mohs E
    Antimicrob Agents Chemother; 1976 Aug; 10(2):205-10. PubMed ID: 984762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Amikacin in a hospital for children: microbiological and clinical studies.
    Marget W; Reindke B; Versmold H
    J Infect Dis; 1976 Nov; 134 SUPPL():S412-9. PubMed ID: 825592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the renal and auditory function of neonates treated with amikacin.
    Parini R; Rusconi F; Cavanna G; Vigliani E; Cornacchia L; Assael BM
    Dev Pharmacol Ther; 1982; 5(1-2):33-46. PubMed ID: 7151635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin.
    Finitzo-Hieber T; McCracken GH; Brown KC
    J Pediatr; 1985 Jan; 106(1):129-36. PubMed ID: 3880819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside-related nephrotoxicity in the premature newborn.
    Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
    Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of amikacin in the neonate.
    Rusconi F; Parini R; Cavanna G; Assael BM
    Ther Drug Monit; 1983 Jun; 5(2):179-83. PubMed ID: 6879642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin doses in very low birthweight newborns.
    Prober CG; Rajchgot P
    Pediatr Pharmacol (New York); 1983; 3(2):125-6. PubMed ID: 6674908
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of an amikacin loading dose for nosocomial infections in very low birthweight infants.
    Berger A; Kretzer V; Gludovatz P; Heinze G; Haiden N; Pollak A
    Acta Paediatr; 2004 Mar; 93(3):356-60. PubMed ID: 15124839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
    Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
    J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
    Mazzei T; Paradiso M; Nicoletti I; Periti P
    J Infect Dis; 1976 Nov; 134 SUPPL():S374-9. PubMed ID: 993629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
    Cook LN; Davis RS; Stover BH
    Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis.
    Wright PF; Kaiser AB; Bowman CM; McKee KT; Trujillo H; McGee ZA
    J Infect Dis; 1981 Feb; 143(2):141-7. PubMed ID: 7012246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended amikacin doses in newborns often produce excessive serum levels.
    Philips JB; Satterwhite C; Dworsky ME; Cassady G
    Pediatr Pharmacol (New York); 1982; 2(2):121-5. PubMed ID: 12760404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.